AngioDynamics

AngioDynamics is a leading of medical devices used by interventional radiologists, nephrologists, and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease. The Company's product line includes market-leading radiofrequency ablation and NanoKnife systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products.

Company Growth (employees)
Type
Public
HQ
Latham, US
Size (employees)
1,300 (est)
AngioDynamics is headquartered in Latham, US

AngioDynamics Office Locations

AngioDynamics has offices in Latham, Amsterdam-Zuidoost, Oakville, Hong Kong and in 1 other location
Latham, US (HQ)
14 Plaza Dr
Denmead, GB
Falcon Court Forest Rd
Hong Kong, HK
72 Gloucester Rd
Oakville, CA
101 2275 Upper Middle Rd E
Amsterdam-Zuidoost, NL
Margriet Toren 75 Haaksbergweg

AngioDynamics Data and Metrics

AngioDynamics Financial Metrics

AngioDynamics's revenue was reported to be $353.9 m in FY, 2016
USD

Revenue (FY, 2016)

353.9 m

Revenue growth (FY, 2015 - FY, 2016), %

(1%)

Gross profit (FY, 2016)

174.3 m

Gross profit margin (FY, 2016), %

49%

Net income (FY, 2016)

(43.6 m)

EBIT (FY, 2016)

1 m

Market capitalization (18-Aug-2017)

632 m

Cash (31-May-2016)

32.3 m

EV

721.1 m
AngioDynamics's current market capitalization is $632 m.
USDFY, 2014FY, 2015FY, 2016

Revenue

354.5 m357 m353.9 m

Revenue growth, %

1%(1%)

Cost of goods sold

174.6 m180.1 m179.6 m

Gross profit

179.9 m176.9 m174.3 m

Gross profit Margin, %

51%50%49%

Sales and marketing expense

84.7 m

R&D expense

25.1 m

General and administrative expense

29.6 m

Operating expense total

166.4 m177.9 m173.3 m

EBIT

13.4 m(994 k)1 m

EBIT margin, %

4%(0%)0%

Interest expense

3.7 m3.2 m3.4 m

Interest income

4 k11 k

Income tax expense

3.3 m(4.7 m)40.3 m

Net Income

3.1 m(3.3 m)(43.6 m)
USDQ1, 2014Q2, 2014Q3, 2015Q1, 2015Q2, 2015Q3, 2016

Revenue

83.7 m89.2 m87.4 m

Cost of goods sold

40.5 m43.4 m43.9 m

Gross profit

43.2 m45.8 m43.5 m

Gross profit Margin, %

52%51%50%

Sales and marketing expense

20.6 m20.6 m20.3 m

R&D expense

6.2 m6.2 m5.8 m

General and administrative expense

7.4 m8.1 m6.8 m

Operating expense total

34.2 m34.8 m32.9 m

EBIT

1.1 m1.3 m2.7 m

EBIT margin, %

1%1%3%

Interest expense

(800 k)(998 k)(809 k)

Interest income

1 k1 k2 k

Income tax expense

83 k(366 k)382 k

Net Income

470 k1.8 m(2.5 m)(757 k)(1.1 m)(489 k)
USDFY, 2014FY, 2015FY, 2016

Cash

16.1 m18.4 m32.3 m

Inventories

61.1 m67.4 m55.4 m

Current Assets

152.2 m155.8 m146.3 m

PP&E

67.2 m54.6 m48.3 m

Goodwill

360.3 m361.3 m361.3 m

Total Assets

800.2 m773.6 m727.1 m

Accounts Payable

32.9 m23.7 m15.6 m

Total Debt

137.7 m121.4 m

Current Liabilities

72.3 m61.2 m66.7 m

Total Liabilities

219.8 m

Additional Paid-in Capital

508.3 m520.1 m525.8 m

Retained Earnings

32.7 m28.2 m(16 m)

Total Equity

545 m507.2 m

Debt to Equity Ratio

0.3 x0.2 x

Debt to Assets Ratio

0.2 x0.2 x

Financial Leverage

1.4 x1.4 x
USDQ1, 2014Q2, 2014Q3, 2015Q1, 2015Q2, 2015Q3, 2016

Cash

13.8 m14.9 m19.7 m20.3 m19 m21.9 m

Inventories

70.4 m75.3 m68.7 m74.3 m70.8 m65.8 m

Current Assets

154.3 m163.4 m157.3 m160 m151.6 m149.4 m

PP&E

51.2 m49.7 m

Goodwill

360.5 m360.5 m360.5 m361.3 m361.3 m361.3 m

Total Assets

796.1 m799.3 m783.1 m771.8 m760.4 m753.5 m

Accounts Payable

29.3 m22 m21.7 m24.9 m21.7 m18.1 m

Current Liabilities

63.7 m57.9 m59.7 m60.7 m60.1 m61.6 m

Additional Paid-in Capital

510.7 m513.4 m518.3 m523 m524.2 m526.5 m

Retained Earnings

32 m33.3 m29 m27.5 m27.1 m27.7 m

Total Equity

547.1 m547.6 m550.7 m

Financial Leverage

1.4 x1.4 x1.4 x
USDFY, 2014FY, 2015FY, 2016

Net Income

3.1 m(3.3 m)(43.6 m)

Depreciation and Amortization

16.8 m17.9 m18 m

Accounts Receivable

(15 m)2.1 m3.1 m

Inventories

(5.4 m)(6.2 m)12 m

Cash From Operating Activities

25.3 m26.2 m45.2 m

Purchases of PP&E

(11.8 m)(11.9 m)(2.3 m)

Cash From Investing Activities

(17 m)(13.3 m)(7.6 m)

Long-term Borrowings

(146.3 m)(20 m)(16.3 m)

Cash From Financing Activities

(14 m)(10.5 m)(23.7 m)

Interest Paid

3.6 m3.2 m3.1 m

Income Taxes Paid

182 k699 k332 k
USDQ1, 2014Q2, 2014Q3, 2015Q1, 2015Q2, 2015Q3, 2016

Net Income

470 k1.8 m(2.5 m)(757 k)(1.1 m)(489 k)

Depreciation and Amortization

6.7 m14 m22.8 m7.2 m14.4 m21.4 m

Accounts Receivable

5.8 m3.1 m3.5 m5.9 m4.9 m2.5 m

Inventories

(9.2 m)(14.1 m)(7.5 m)(6.9 m)(3.5 m)1.5 m

Cash From Operating Activities

5.4 m3.2 m15.4 m4.7 m14.3 m26.7 m

Purchases of PP&E

(5.1 m)(7.5 m)(11 m)(743 k)(1.2 m)(1.9 m)

Cash From Investing Activities

(5.3 m)(7.8 m)(12 m)(743 k)(1.1 m)(3.9 m)

Long-term Borrowings

(1.3 m)(2.5 m)(8.8 m)(1.3 m)(3.8 m)(11.3 m)

Cash From Financing Activities

(2.4 m)3.4 m641 k(2.1 m)(12.4 m)(19.2 m)
USDY, 2016

EV/EBIT

708.3 x

EV/CFO

15.9 x

Revenue/Employee

272.2 k

Debt/Equity

0.2 x

Debt/Assets

0.2 x

Financial Leverage

1.4 x

AngioDynamics Market Value History

Traffic Overview of AngioDynamics

AngioDynamics Online and Social Media Presence

AngioDynamics Company Life and Culture

You may also be interested in